1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Brian Jonas: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure Azacitidine, Decitabine, Venetoclax - Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 2 | Recruiting | Brian Jonas | 20 | 2022-02-09 | 2024-05-29 |
Azacitidine (1) · Decitabine (1) · Injections (1) · venetoclax (1)
United States (1)
Brian A Jonas (1)
P30CA093373 (1)